文献速递眼底病与葡萄膜炎

光谱分辨眼底自发荧光作为中期与萎缩性AMD视网膜代谢完整性生物标志物

Spectrally Resolved Fundus Autofluorescence as a Biomarker of Retinal Metabolic Integrity in Intermediate and Atrophic AMD.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该横断面观察性研究分析62眼(62例)AMD患者的775幅SD-OCT B扫描,按既定OCT标准分类为290个玻璃膜疣、49个iRORA、390个cRORA和46个nGA。采用450nm波长Sr-FAF定量REFC与GEFC,发现各病灶类型间REFC(F=59.3,P<0.001)与GEFC(F=13.5,P<0.001)均有显著差异。玻璃膜疣REFC高于iRORA、cRORA和nGA(均P<0.001),GEFC高于cRORA(P<0.001)和nGA(P=0.002);波长从玻璃膜疣至iRORA、nGA、cRORA逐步降低,病灶大小是回归分析中最强预测因子(β=-0.31,P<0.001)。结论认为Sr-FAF可揭示AMD病灶类型间不同的代谢特征,联合SD-OCT或有助于早期萎缩检测与风险分层。

要点

  • Sr-FAF在AMD不同病灶类型间显示显著不同的荧光信号特征。
  • 玻璃膜疣REFC和GEFC较高,提示光感受器-RPE活性尚存。
  • cRORA与nGA信号降低,反映晚期萎缩性改变。

核心结论

  • Sr-FAF可揭示AMD各病灶类型间不同的代谢特征,联合SD-OCT可能增强早期萎缩性改变的检测并改善AMD风险分层。

研究设计与样本

  • 横断面观察性研究,纳入62眼(62例)中期与萎缩性AMD患者,分析775幅SD-OCT B扫描。
  • 病灶按既定OCT标准分类:290个玻璃膜疣、49个iRORA、390个cRORA、46个nGA。
  • 所有眼行SD-OCT(97幅B扫描)及450nm波长Sr-FAF,用定制软件定量REFC与GEFC,组间比较采用单因素方差分析及Scheffé事后检验。

主要发现

  • 各病灶类型间REFC(F=59.3,P<0.001)与GEFC(F=13.5,P<0.001)均有显著差异。
  • 玻璃膜疣REFC高于iRORA、cRORA和nGA(均P<0.001),GEFC高于cRORA(P<0.001)和nGA(P=0.002)。
  • 波长(nm)从玻璃膜疣至iRORA、nGA、cRORA逐步降低。
  • 病灶大小(像素)差异显著(iRORA<nGA<玻璃膜疣<cRORA;P<0.001),且为回归分析中最强预测因子(β=-0.31,P<0.001)。

临床怎么用

  • Sr-FAF可作为SD-OCT的补充手段,用于评估AMD病灶的代谢状态并辅助风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the association between spectrally resolved fundus autofluorescence (Sr-FAF) signals and four macular lesion types identified on spectral-domain optical coherence tomography (SD-OCT): (1) drusen, (2) incomplete retinal pigment epithelial and outer retinal atrophy (iRORA) and complete retinal pigment epithelium and outer retinal atrophy (cRORA), (3) retinal pigment epithelium (RPE) and outer retinal atrophy, and (4) nascent geographic atrophy (nGA) in eyes with intermediate and atrophic age-related macular degeneration (AMD). METHODS: This cross-sectional observational study analyzed 775 SD-OCT B-scans from 62 eyes (62 patients) with AMD. Lesions were classified according to established OCT criteria (290 drusen, 49 iRORA, 390 cRORA, 46 nGA). All eyes underwent SD-OCT imaging (97 B-scans) and Sr-FAF using a 450-nm wavelength. Quantitative Sr-FAF metrics (average red emission fluorescence component [REFC] and average green emission fluorescence component [GEFC]) were determined using custom software, and lesion groups were compared via one-way analysis of variance with Scheffé post hoc testing. RESULTS: Significant differences among lesion types were observed for REFC (F = 59.3, P < 0.001) and GEFC (F = 13.5, P < 0.001). Drusen exhibited higher REFC intensities than iRORA, cRORA, and nGA (all P < 0.001), and higher GEFC intensities than cRORA (P < 0.001) and nGA (P = 0.002). Wavelength (nm) progressively decreased from drusen to iRORA, nGA, and cRORA. Lesion size (in pixels) differed significantly (iRORA < nGA < drusen < cRORA; P < 0.001) and was the strongest predictor (β = -0.31, P < 0.001) in the regression analysis. CONCLUSIONS: Sr-FAF reveals distinct metabolic signatures across AMD lesion types. Higher fluorophore signals in drusen suggest preserved photoreceptor-RPE activity, whereas reduced signals in cRORA and nGA reflect advanced atrophy. Combined SD-OCT and Sr-FAF may enhance the detection of early atrophic changes and improve AMD risk stratification.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Vujosevic S, Zanzottera E, Brotto L, et al. Spectrally Resolved Fundus Autofluorescence as a Biomarker of Retinal Metabolic Integrity in Intermediate and Atrophic AMD. Invest Ophthalmol Vis Sci. 2026. PMID: 42132461. doi:10.1167/iovs.67.5.31

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。